Featured Research

from universities, journals, and other organizations

New Technique Appears To Stop Abnormal Blood Vessel Growth

Date:
June 14, 2005
Source:
Medical College of Georgia
Summary:
Dr. Balamurali K. Ambati, corneal specialist at the Medical College of Georgia, is studying a new approach to halting growth of blood vessels that can cause blindness or help tumors survive.

Dr. Balamurali K. Ambati, corneal specialist at the Medical College of Georgia, is studying a new approach to halting growth of blood vessels that can cause blindness or help tumors survive.
Credit: Image courtesy of Medical College of Georgia

A manmade protein with a tail of amino acids delivered to target cells can dramatically reduce blood vessel growth that obstructs vision or feeds a tumor, researchers have found.

This new approach to inhibiting blood vessel growth, or angiogenesis, delivers “intraceptors” that sequester VEGF, a “linchpin” protein needed to make blood vessels, says Dr. Balamurali K. Ambati, corneal specialist at the Medical College of Georgia and corresponding author on the study.

In a test tube as well as animal models for corneal injury and the deadly skin cancer, melanoma, MCG researchers have reduced destructive blood vessel proliferation by up to two-thirds. Findings are published in the May issue of Investigative Ophthalmology & Visual Science.

“We have a promising new preclinical approach to treat conditions that involve blood vessel formation,” says Dr. Ambati. These include corneal injury, the blinding wet form of macular degeneration, diabetic retinopathy and tumors, which need blood and oxygen to survive.

Other angiogenesis inhibitors in use or under study target VEGF (vascular endothelial growth factor) after it has moved outside the cell, says Dr. Ambati, reducing new blood vessel growth by 30 percent to 50 percent.

“In theory, our approach works several steps ahead of where existing angiogenesis inhibitors work,” he says. “The idea is that, hopefully, this would give you a therapeutic advantage by stopping VEGF where it’s produced. Scientists have found that several types of cells, including blood vessel cells and cancer cells, can make their own VEGF and receptor. If you have a junkie shooting up and making his own drug, you need to get inside him to break that cycle; getting his dealer is not enough. We have focused our research on attacking VEGF within cells. We want to break that autocrine loop,” he says of the cell’s ability to supply itself with VEGF and a receptor.

To keep VEGF from ever leaving the protein factory where it’s made, MCG researchers created a gene that makes a version of Flt, a VEGF receptor identified nearly a decade ago, that has a tail of amino acids. The amino acid tail, a retention signal called KDEL, transforms Flt into a homing device and a death sentence for VEGF.

“It’s an arrest mechanism essentially,” says Dr. Ambati. “It will bind and sequester. If you are VEGF and I am Flt-KDEL complex, I am going to grab you and keep you from leaving the room.” If a protein spends too much time in the factory, called the endoplasmic reticulum, the cell destroys it.

The researchers get intraceptors inside cells by putting the manmade gene that makes them inside a carrier called a plasmid, an approach used in gene therapy and naturally by bacteria in the body to carry around extra genes.

Preliminary evidence indicates this technology can not only prevent blood vessel formation but also help eliminate existing blood vessels, Dr. Ambati says.

Much laboratory work remains before clinical trials are considered, he says. The researchers need to study the process in the retina, the target of abnormal blood vessel growth that occurs in the wet form of macular degeneration as well as diabetic retinopathy. He plans to do additional cancer studies and longer-term follow up the technology’s ability to forestall destructive new growth. Meanwhile, the MCG Office of Technology Transfer and Economic has obtained a provisional patent on the technology.

Other authors on the paper include Dr. Nirbhai Singh, MCG postdoctoral fellow working with Dr. Ambati; Shivan Amin, a rising fourth-year medical student, Elizabeth Richter, a rising third-year M.D.-Ph.D. student andVincent Scoglietti, a rising third-year medical student; Saadia Rashid, Pooja D. Jani, Rajwinder Kaur, who work in Dr. Ambati’s lab; Dr. Jayakrishna Ambati, a retina specialist at the University of Kentucky; Dr. Zheng Dong, MCG cell biologist and Dr. Jin Wang, a postdoctoral fellow in Dr. Dong’s lab.


Story Source:

The above story is based on materials provided by Medical College of Georgia. Note: Materials may be edited for content and length.


Cite This Page:

Medical College of Georgia. "New Technique Appears To Stop Abnormal Blood Vessel Growth." ScienceDaily. ScienceDaily, 14 June 2005. <www.sciencedaily.com/releases/2005/06/050614003220.htm>.
Medical College of Georgia. (2005, June 14). New Technique Appears To Stop Abnormal Blood Vessel Growth. ScienceDaily. Retrieved September 2, 2014 from www.sciencedaily.com/releases/2005/06/050614003220.htm
Medical College of Georgia. "New Technique Appears To Stop Abnormal Blood Vessel Growth." ScienceDaily. www.sciencedaily.com/releases/2005/06/050614003220.htm (accessed September 2, 2014).

Share This




More Health & Medicine News

Tuesday, September 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Snack Attack: Study Says Action Movies Make You Snack More

Snack Attack: Study Says Action Movies Make You Snack More

Newsy (Sep. 2, 2014) You're more likely to gain weight while watching action flicks than you are watching other types of programming, says a new study published in JAMA. Video provided by Newsy
Powered by NewsLook.com
U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

Newsy (Sep. 2, 2014) The U.N. says the problem is two-fold — quarantine zones and travel restrictions are limiting the movement of both people and food. Video provided by Newsy
Powered by NewsLook.com
Doctors Fear They're Losing Battle Against Ebola

Doctors Fear They're Losing Battle Against Ebola

AP (Sep. 2, 2014) As a third American missionary is confirmed to have contracted Ebola in Liberia, doctors on the ground in West Africa fear they're losing the battle against the outbreak. (Sept. 2) Video provided by AP
Powered by NewsLook.com
Tech Giants Bet on 3D Headsets for Gaming, Healthcare

Tech Giants Bet on 3D Headsets for Gaming, Healthcare

AFP (Sep. 2, 2014) When Facebook acquired the virtual reality hardware developer Oculus VR in March for $2 billion, CEO Mark Zuckerberg hailed the firm's technology as "a new communication platform." Duration: 02:24 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins